+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Agenus Inc - logo

Agenus is an immuno-oncology company that focuses on the discovery and development of treatments that engage the body's immune system for patients suffering with cancer. The company offers Retrocyte Display, an antibody discovery platform that screens and generates therapeutic antibody drug candidates. It is also developing Prophage, a heat shock protein-based autologous vaccine. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or OX40L Receptor or CD134 or TNFRSF4) - Pipeline Review, H1 2019 - Product Thumbnail Image

Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or OX40L Receptor or CD134 or TNFRSF4) - Pipeline Review, H1 2019

  • Drug Pipelines
  • April 2019
  • 85 Pages
  • Global
From
TIM3 Inhibitors Drug Clinical Trials & Market Opportunity Insight 2028 - Product Thumbnail Image

TIM3 Inhibitors Drug Clinical Trials & Market Opportunity Insight 2028

  • Report
  • July 2022
  • 111 Pages
  • Global
From
Display Library Technologies and Affiliated Services Market by Type of Technology, Type of Molecule, and Key Geographical Regions, Industry Trends and Global Forecasts: 2021-2030 - Product Thumbnail Image

Display Library Technologies and Affiliated Services Market by Type of Technology, Type of Molecule, and Key Geographical Regions, Industry Trends and Global Forecasts: 2021-2030

  • Report
  • June 2021
  • 220 Pages
  • Global
From
Pancreatic Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 4317 Pages
  • Global
From
Melanoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Melanoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 3809 Pages
  • Global
From
Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2024 - Product Thumbnail Image

Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Potassium Channel Blocker Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Potassium Channel Blocker Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • June 2023
  • 118 Pages
  • Global
From
Genital Herpes - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Genital Herpes - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • October 2021
  • 119 Pages
  • Global
From
Angiosarcoma - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Angiosarcoma - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • September 2021
  • 126 Pages
  • Global
From
Comprehensive Report on Agenus Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Agenus Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Agenus Inc (AGEN) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Agenus Inc (AGEN) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • September 2024
  • 53 Pages
From
Loading Indicator